Verona Pharma Plc Stock Price on December 2, 2024
| VRNA Stock | USD 41.42 2.16 5.50% |
Below is the normalized historical share price chart for Verona Pharma PLC extending back to April 27, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Verona Pharma stands at 41.42, as last reported on the 13th of December 2024, with the highest price reaching 41.42 and the lowest price hitting 39.26 during the day.
If you're considering investing in Verona Stock, it is important to understand the factors that can impact its price. Verona Pharma appears to be very steady, given 3 months investment horizon. Verona Pharma PLC owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.19, which indicates the firm had a 0.19% return per unit of risk over the last 3 months. By inspecting Verona Pharma's technical indicators, you can evaluate if the expected return of 0.54% is justified by implied risk. Please review Verona Pharma's Coefficient Of Variation of 620.86, risk adjusted performance of 0.1243, and Semi Deviation of 1.73 to confirm if our risk estimates are consistent with your expectations.
At present, Verona Pharma's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 323.5 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 75.3 M. . The current year's Price Earnings To Growth Ratio is expected to grow to 0.63, whereas Price To Sales Ratio is forecasted to decline to 4,122. Verona Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 27th of April 2017 | 200 Day MA 23.3534 | 50 Day MA 35.9567 | Beta 0.424 |
Verona |
Sharpe Ratio = 0.1902
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | VRNA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.81 actual daily | 25 75% of assets are more volatile |
Expected Return
| 0.54 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
| 0.19 actual daily | 14 86% of assets perform better |
Based on monthly moving average Verona Pharma is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Verona Pharma by adding it to a well-diversified portfolio.
Price Book 25.059 | Enterprise Value Ebitda (20.89) | Price Sales 581.4322 | Shares Float 392.2 M | Wall Street Target Price 47.2857 |
Verona Pharma Main Headline on 2nd of December 2024
Disposition of 3200 shares by David Zaccardelli of Verona Ph... by David Zaccardelli
Filed transaction by Verona Pharma PLC Director, Officer: President And Ceo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Verona Pharma Valuation on December 2, 2024
It is possible to determine the worth of Verona Pharma on a given historical date. On December 2, 2024 Verona was worth 40.1 at the beginning of the trading date compared to the closed value of 39.11. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Verona Pharma stock. Still, in general, we apply an absolute valuation method to find Verona Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Verona Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Verona Pharma's related companies.
| Open | High | Low | Close | Volume | |
| 40.60 | 40.76 | 39.59 | 39.63 | 475,159 | |
12/02/2024 | 40.10 | 40.43 | 38.92 | 39.11 | 383,676 |
| 38.81 | 39.58 | 38.50 | 38.66 | 546,872 |
| Backtest Verona Pharma | | | Verona Pharma History | | | Verona Pharma Valuation | Previous | Next |
Verona Pharma Trading Date Momentum on December 2, 2024
| On December 03 2024 Verona Pharma PLC was traded for 38.66 at the closing time. The top price for the day was 39.58 and the lowest listed price was 38.50 . The trading volume for the day was 546.9 K. The trading history from December 3, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 1.15% . The trading price change against the current closing price is 0.28% . |
Verona Pharma PLC Fundamentals Correlations and Trends
By evaluating Verona Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Verona Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Verona financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Verona Pharma Stock history
Verona Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Verona is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Verona Pharma PLC will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Verona Pharma stock prices may prove useful in developing a viable investing in Verona Pharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 79.3 M | 75.3 M | |
| Net Loss | -61.8 M | -58.7 M |
Verona Pharma Quarterly Net Working Capital |
|
Verona Pharma Stock Technical Analysis
Verona Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Verona Pharma Period Price Range
Low | December 13, 2024
| High |
0.00 | 0.00 |
Verona Pharma PLC cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Verona Pharma December 13, 2024 Market Strength
Market strength indicators help investors to evaluate how Verona Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Verona Pharma shares will generate the highest return on investment. By undertsting and applying Verona Pharma stock market strength indicators, traders can identify Verona Pharma PLC entry and exit signals to maximize returns
Verona Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Verona Pharma's price direction in advance. Along with the technical and fundamental analysis of Verona Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Verona to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1243 | |||
| Jensen Alpha | 0.4097 | |||
| Total Risk Alpha | 0.0467 | |||
| Sortino Ratio | 0.1532 | |||
| Treynor Ratio | 2.62 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Verona Stock analysis
When running Verona Pharma's price analysis, check to measure Verona Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verona Pharma is operating at the current time. Most of Verona Pharma's value examination focuses on studying past and present price action to predict the probability of Verona Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verona Pharma's price. Additionally, you may evaluate how the addition of Verona Pharma to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |